Braveheart Bio
PrivateLast Round
Series A
Nov 5, 2025
Total Funding Raised
$185M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Braveheart Bio is a biotechnology company developing novel therapeutics for hypertrophic cardiomyopathy and related cardiovascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Braveheart Bio Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Braveheart Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 5, 2025 |
Key People
Founding team and executive leadership
Braveheart Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| Enavate Sciences | Series A |
| Forbion | Series A |
| OrbiMed | Series A |
| Frazier Life Sciences | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 6, 2026
Grew 35% QoQ, from 20 to 27 employees.
- Mar 31, 2026
Lee Bockus joins as Senior Medical Director.
Braveheart Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Braveheart Bio's valuation, stock price, and market status.